Related Experiment Videos

Anticipating potential linezolid-SSRI interactions in the general hospital setting: an MAOI in disguise

Christopher L Sola1, J Michael Bostwick, Dionne A Hart

  • 1Department of Psychiatry and Psychology, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA.

Mayo Clinic Proceedings
|March 15, 2006
PubMed

Insights

Linezolid, an antibiotic, inhibits monoamine oxidase, risking severe interactions with antidepressants like SSRIs. Medical practitioners must be aware of these risks to prevent hypertensive crisis or serotonin syndrome.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Neuroscience

Background:

  • Linezolid is a novel antibiotic effective against resistant Gram-positive bacteria.
  • Linezolid possesses monoamine oxidase inhibitory (MAOI) properties.
  • MAOIs are known to cause serious drug interactions, particularly with antidepressants.

Observation:

  • The MAOI activity of linezolid can lead to life-threatening adverse events.
  • These interactions may be unfamiliar to non-psychiatric medical and surgical practitioners.
  • Clinical scenarios involving linezolid and SSRI interactions are presented.

Findings:

  • Linezolid's MAOI activity poses a risk for hypertensive crisis and serotonin syndrome.
  • Awareness of these interactions is crucial for safe linezolid prescription.
  • Three clinical cases illustrate potential or actual linezolid-SSRI interactions.

Implications:

  • Enhanced practitioner education on linezolid's MAOI properties is necessary.
  • Improved clinical vigilance is required to prevent adverse drug events.
  • This review highlights the importance of considering drug interactions in antimicrobial therapy.

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...